Head-to-head · Value Score
CoreAge Rx vs MEDGm
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, MEDGm a 64. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade B · Good Value
Advertised price
From $79/mo
From $79/mo (compounded semaglutide; confirm total at checkout)
MEDGm
Grade C · Watch List
Advertised price
$299/mo month-to-month
$299/mo month-to-month (the $179 headline is the first month only, after an automatic welcome coupon)
The verdict
CoreAge Rx takes it on Value Score, 81 to 64 — an est. From $79/mo (compounded semaglutide; confirm total at checkout) first month, though we flag its pricing to watch. MEDGm isn't out of it: Shoppers who want an oral tablet and an injection from the same desk with four named pharmacies behind them, and who will price month two before month one.
CoreAge Rx is a featured partner of this site. Its advertised prices have checkout conditions, and state eligibility is confirmed during intake.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | MEDGm |
|---|---|---|
| Value Score | 81 (B) | 64 (C) |
| Advertised price | From $79/mo (compounded semaglutide; confirm total at checkout) | $299/mo month-to-month (the $179 headline is the first month only, after an automatic welcome coupon) |
| Save vs brand self-pay | — | — |
| Semaglutide | From $79/mo (compounded injection; confirm total at checkout) | $299/mo month-to-month (the $179 headline is the first month only, after an automatic welcome coupon) |
| Tirzepatide | From $129/mo (compounded injection; confirm total at checkout) | $399/mo month-to-month (the $279 headline is the first month only) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | U.S., state limits shown at intake | All 50 states and D.C. |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.
What's good
- CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
- CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
- The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
- CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
- CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
- CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.
The fine print
- CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
- CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
- CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
- CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
- CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
- CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.
MEDGm
Compounded semaglutide at $299 a month and tirzepatide at $399, sold behind a "starting at $179" headline that is a first-month coupon — on a site whose own questions promise the price never increases.
What's good
- MEDGm names four dispensing pharmacies with street addresses, phone numbers and websites, so you can look each one up before you order
- The full MEDGm ladder is shown before payment with real totals: $597, $1,134 and $2,028 for three, six and twelve months of semaglutide, and $897, $1,734 and $3,228 for tirzepatide
- An oral dissolving semaglutide tablet is sold alongside the injection at a published $369 a month, so the needle-free route has a price rather than a waiting list
- Coverage is stated as the fifty states and the District of Columbia and matches the intake's own list exactly — no hedge that contradicts the claim, and nothing narrower hidden in the terms
- The prescribing medical groups are named as entities, state by state, and the terms state the auto-renewal mechanics in full rather than leaving them to be discovered
- The company's state of formation and governing law are published, and support has a phone number and an address under the brand
The fine print
- MEDGm's first month is a coupon. The month-to-month panel shows $179 for semaglutide only because an automatic code takes $120 off the $299 standing rate
- The same MEDGm coupon applies to the other two products: tirzepatide is $279 in the first month against a $399 standing rate, and the oral tablet $249 against $369, so month two is the price to plan around
- The treatment page's own questions say "your price never increases, even as your dose goes up" on a plan whose price increases by $120 at the first renewal — the sentence is true about the dose and false about the month
- The prepay bundles are charged in full up front and auto-renew into another full term, up to ten days early, unless canceled at least seventy-two hours ahead — so a twelve-month plan can become a second $2,028 or $3,228 charge
- The savings figures printed on the ladder are calculated against the standing rate, which is only ever billed on the month-to-month plan, and the same three figures appear on the oral tab where the standing rate is different
- MEDGm's 'starting at $169' headline is the twelve-month rate, billed $2,028 up front, not a price you can pay month to month
- No clinician is named and no identifier is published — only medical-group entities — and which of the four pharmacies is 503A or 503B, or fills which state, is not stated
- No principal place of business is published anywhere; the only addresses on the site belong to the four pharmacies and a state regulator notice
- The signup prints a clinical match, a success probability of one hundred percent and a headline saying the prescription plan is approved, all before payment and before any clinician has seen the file
- The questions say a candidate is likely suitable at a body mass index of 20 or above, which is inside the normal range
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to MEDGm.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.